KR20190088510A - 항체 에세이 - Google Patents

항체 에세이 Download PDF

Info

Publication number
KR20190088510A
KR20190088510A KR1020197018129A KR20197018129A KR20190088510A KR 20190088510 A KR20190088510 A KR 20190088510A KR 1020197018129 A KR1020197018129 A KR 1020197018129A KR 20197018129 A KR20197018129 A KR 20197018129A KR 20190088510 A KR20190088510 A KR 20190088510A
Authority
KR
South Korea
Prior art keywords
tumor marker
epcam
panel
aif1
mmp9
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020197018129A
Other languages
English (en)
Korean (ko)
Inventor
자레드 앨런
이사벨 맥도널드
안드리아 머레이
크리스토퍼 웰버리
Original Assignee
오엔씨이뮨리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 오엔씨이뮨리미티드 filed Critical 오엔씨이뮨리미티드
Publication of KR20190088510A publication Critical patent/KR20190088510A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • G01N33/57438—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57525—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the liver or pancreas
    • G01N33/57484—
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5758—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumours, cancers or neoplasias, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides or metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Gastroenterology & Hepatology (AREA)
KR1020197018129A 2016-11-25 2017-11-24 항체 에세이 Withdrawn KR20190088510A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1619954.9 2016-11-25
GBGB1619954.9A GB201619954D0 (en) 2016-11-25 2016-11-25 Antibody assay
PCT/GB2017/053541 WO2018096351A1 (en) 2016-11-25 2017-11-24 Antibody assay

Publications (1)

Publication Number Publication Date
KR20190088510A true KR20190088510A (ko) 2019-07-26

Family

ID=58073509

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020197018129A Withdrawn KR20190088510A (ko) 2016-11-25 2017-11-24 항체 에세이

Country Status (13)

Country Link
US (1) US20190376975A1 (https=)
EP (1) EP3545309B1 (https=)
JP (1) JP7249284B2 (https=)
KR (1) KR20190088510A (https=)
CN (2) CN108107218B (https=)
AU (1) AU2017365931A1 (https=)
BR (1) BR112019010636A2 (https=)
CA (1) CA3044492A1 (https=)
GB (1) GB201619954D0 (https=)
IL (1) IL266857A (https=)
MX (1) MX2019006098A (https=)
RU (1) RU2769987C2 (https=)
WO (1) WO2018096351A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109116023B (zh) * 2018-06-14 2021-06-04 郑州大学第一附属医院 一种肺癌标志物抗-mmp12自身抗体及其应用
CN109709335B (zh) * 2018-12-18 2020-10-27 中国医学科学院基础医学研究所 热休克蛋白hspa4在肿瘤转移预测、预后评估和治疗中的应用
CN109633165B (zh) * 2018-12-18 2021-03-09 中国医学科学院基础医学研究所 抗hspa4自身抗体作为乳腺癌诊断或预后评估标志物的应用
ES3039706T3 (en) * 2019-02-19 2025-10-24 Otsuka Denshi Kk Method for determining condition parameters for photodynamic therapy and photodynamic therapy apparatus
CN110579611B (zh) * 2019-09-18 2023-01-31 郑州大学 一种用于肺癌早期筛查和诊断的联合检测血清标志物、试剂盒及检测方法
JPWO2022118947A1 (https=) * 2020-12-04 2022-06-09
CN114994318A (zh) * 2022-06-16 2022-09-02 深圳上泰生物工程有限公司 一种用于检测akr1b10的试剂盒及其制备方法
CN116444680B (zh) * 2022-12-28 2024-05-03 杭州凯保罗生物科技有限公司 一种ralgds-krt8-aif1融合肿瘤抗原蛋白的制备方法及其应用
CN119639903B (zh) * 2025-01-17 2025-11-25 中山大学肿瘤防治中心（中山大学附属肿瘤医院、中山大学肿瘤研究所） 用于肝内胆管癌的生物标记物、药物及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7387881B2 (en) * 2001-09-19 2008-06-17 The Regents Of The University Of Michigan Detection and treatment of cancers of the liver
ITPD20030264A1 (it) * 2003-10-30 2005-04-30 Xeptagen Spa Metodo di diagnosi altamente specifico per neoplasie
TWI281473B (en) * 2003-12-19 2007-05-21 Ind Tech Res Inst Biomarkers for liver diseases and method for using same
CN1632589A (zh) * 2003-12-24 2005-06-29 财团法人工业技术研究院 肝脏疾病的生物标记分子及其检测方法
US20080254481A1 (en) * 2006-11-13 2008-10-16 Invitrogen Corporation Methods and kits for detecting prostate cancer biomarkers
CN102301237B (zh) * 2008-12-02 2014-05-14 财团法人工业技术研究院 用于肝纤维化诊断的生物标记
CN102356316B (zh) * 2009-03-05 2015-07-08 独立行政法人产业技术综合研究所 肝内胆管癌的检出、辨别方法
US20120309034A1 (en) * 2010-02-12 2012-12-06 Nitto Boseki Co., Ltd. METHOD FOR MEASURING IMMUNITY OF COMPLEX OF Ku86 AND AUTOANTIBODY THEREOF, KIT USED THEREFOR, AND METHOD FOR DETERMINING CANCER USING SAME
CN102175864A (zh) * 2011-01-19 2011-09-07 江苏永鼎股份有限公司 一组早期肝癌分子标志物及其应用
CN102507938B (zh) * 2011-10-08 2014-12-24 复旦大学附属中山医院 一种肝癌转移预测定量抗体芯片及试剂盒
US20150185226A1 (en) * 2012-07-23 2015-07-02 Inserm (Institut National De La Sante Et La Recherche Medicale) Method for Diagnosing Scleroderma
JP2014240771A (ja) * 2013-06-11 2014-12-25 日東紡績株式会社 Ｋｕ７０／Ｋｕ８６ヘテロダイマーに対する自己抗体の免疫測定方法、それに用いるキットおよびそれを用いた癌判定方法
GB201320061D0 (en) * 2013-11-13 2013-12-25 Electrophoretics Ltd Materials nad methods for diagnosis and prognosis of liver cancer
GB201411060D0 (en) * 2014-06-20 2014-08-06 Oncimmune Ltd Improved immunoassay method
TWI700493B (zh) * 2014-07-02 2020-08-01 香港商龍勝發展有限公司 用於非侵入性肝癌診斷之特異性生物標記組
CN104990905B (zh) * 2015-06-30 2017-12-29 曲凯 一种基于固相酶联免疫荧光斑点的肝癌转移诊断试剂盒

Also Published As

Publication number Publication date
CN108107218B (zh) 2021-10-08
JP7249284B2 (ja) 2023-03-30
WO2018096351A1 (en) 2018-05-31
CN108107218A (zh) 2018-06-01
JP2020515826A (ja) 2020-05-28
RU2019118625A3 (https=) 2021-03-31
CA3044492A1 (en) 2018-05-31
EP3545309A1 (en) 2019-10-02
AU2017365931A1 (en) 2019-06-06
RU2019118625A (ru) 2020-12-25
GB201619954D0 (en) 2017-01-11
US20190376975A1 (en) 2019-12-12
IL266857A (en) 2019-07-31
MX2019006098A (es) 2019-12-02
RU2769987C2 (ru) 2022-04-12
EP3545309B1 (en) 2021-03-31
CN113655224A (zh) 2021-11-16
BR112019010636A2 (pt) 2019-10-01

Similar Documents

Publication Publication Date Title
CN111337678B (zh) 与肿瘤免疫治疗效果相关的生物标志物及其应用
EP3545309B1 (en) Antibody assay
JP4876127B2 (ja) 改善されたイムノアッセイ法
CN106662586B (zh) 改进的免疫测定方法
US20090047689A1 (en) Autoantigen biomarkers for early diagnosis of lung adenocarcinoma
US20090169575A1 (en) Proteins
EP2544004B1 (en) Gastric cancer marker, and method for detecting gastric cancer
EP2544005B1 (en) Gastric cancer marker, and method for detecting gastric cancer
NO20161585A1 (no) Forbedrede immunoassay metoder
EP3701264B1 (en) Method and means for diagnosing autoimmune hepatitis using autoantibody markers
JP7744641B2 (ja) 肺癌における自己抗体を検出するための抗原の組合せの使用
EP2570813A2 (en) Method for the diagnosis/prognosis of colorectal cancer
US20230375550A1 (en) Method for diagnosing breast cancer by using biomarker
TW201928351A (zh) 抗體測定
GB2600701A (en) Antibody assay
CN113933509A (zh) 抗体测定

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PC1202 Submission of document of withdrawal before decision of registration

St.27 status event code: N-1-6-B10-B11-nap-PC1202

WITB Written withdrawal of application
R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

PN2301 Change of applicant

St.27 status event code: A-3-3-R10-R13-asn-PN2301

St.27 status event code: A-3-3-R10-R11-asn-PN2301

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000